|Table of Contents|

Research Progress of the Value and Utilization of Taxus chinensis(PDF)

《北方园艺》[ISSN:1001-0009/CN:23-1247/S]

Issue:
2013年12期
Page:
192-195
Research Field:
Publishing date:

Info

Title:
Research Progress of the Value and Utilization of Taxus chinensis
Author(s):
WANG Hong-pingDUAN Hong-mei
Department of Biology and Chemistry,Wenshan University,Wenshan,Yunnan 663000)
Keywords:
Chinese yewmedicinal valuepaclitaxeldevelopment and utilization
PACS:
S 688
DOI:
-
Abstract:
Taxus chinensis is the important source of paclitaxel the anti-cancer drug taxol and its’ semi-synthetic precursors,and it received widespread attention in recent decades.In this article,the resources were described,mainly focused on the chemical constituents,medicinal value and pharmacological action of paclitaxel.The development of paclitaxel from Taxus chinensis and the economic benefit,ecological benefit and green value were summarized in order to provide a reference for the development and utilization.

References:

[1]徐怀德.天然产物提取工艺学[M].上海:上海交通大学出版社,2006:422.
[2]陈际伸,黄宝龙.红豆杉资源与紫杉醇研究进展[J].江西林业科技,1998(4):33-36.
[3]吴彦,刘庆,胡科,等.我国红豆杉资源现状和紫杉醇产业化对策[J].长江流域资源与环境,2002(11):516-519. [4]贺立虎,李娟丽,周瑾.红豆杉资源的开发与利用[J].杨凌职业技术学院学报,2007(6):9-11.
[5]马明东,刘跃建.红豆杉资源及开发利用综述[J].四川林业科技,2004,25:22-25.
[6]王卫斌,郭华,王达明,等.我国的云南红豆杉资源及其药用原料林培育技术的研究进展[J].西部林业科学,2007,36:123-128.
[7]张学玉,曲玮,梁敬钰.红豆杉属植物化学成分及药理作用研究进展[J].海峡药学,2011(23):5-8.
[8]李存芳,刘勇,董玫,等.南方红豆杉化学成分的研究进展[J].中草药,2007,38(8):1121-1131.
[9]陈长柏.红豆杉的药用价值[J].林木花卉,2009(24):46.
[10]王卫斌,姜远标.红豆杉的药用价值与紫杉醇药源的开发利用[J].中国林业产业,2006(10):42-45.
[11]陈河,田菊霞.红豆杉活性成分巴卡亭III对大鼠肺纤维化的干预作用[J].浙江中医杂志,2009(3):192-193. [12]费永俊.红豆杉药用价值评价及解决药源危机的途径[J].时珍国医国药,1997(5):463-464.
[13]刘福和,倪文娟.紫杉醇的药理与临床研究进展[J].临床医学,2011(24):3812 .
[14]胡道伟,梅运军,刘凌,等.红豆杉物种资源的开发利用[J].中药与天然药物,2001(13):57-59.
[15]吴吴显,樊天义.红豆杉的开发前景[J].适用技术市场,2001(12):13.
[16]杜玲玲,谢志慧,李效贤.红豆杉属植物研究进展[J].药物与临床,2008(17):118-121.
[17]李延红.红豆杉开发利用的现状研究[J].生物及医药技术,2007(21):108-110.
[18]张炯炯.红豆杉植物资源的开发利用[J].生物学杂志,2000(4):121-125.

Memo

Memo:
-
Last Update: 2014-08-20